Samalin Investment Counsel, LLC Biogen Inc. Transaction History

Samalin Investment Counsel, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$187.54 - $223.02 $24,755 - $29,438	-132 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$259.0 - $414.71 $34,188 - $54,741	132 New	132 $45,000
Q1 2021 May 11, 2021	SELL	$242.95 - $284.63 $43,731 - $51,233	-180 Closed	0 $0
Q3 2020 Nov 10, 2020	BUY	$264.77 - $305.71 $47,658 - $55,027	180 New	180 $51,000
Q1 2020 May 04, 2020	SELL	$268.85 - $341.04 $35,488 - $45,017	-132 Closed	0 $0
Q4 2019 Feb 05, 2020	BUY	$220.06 - $304.07 $29,047 - $40,137	132 New	132 $39,000

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Samalin Investment Counsel, LLC, based on Form 13F filings with the SEC.

Stay updated on Samalin Investment Counsel, LLC with notifications on news.